2m 2m 2m 2m 2m 2m 2m
INOVIO PHARMA (INO)
NASDAQ
$1.19-$0.02 (-2.07%)
Price as of Oct 02, 2026 6:18 PM EDT- $125.1MMarket Cap
- -50.81%1-Year Change
- BiotechnologyIndustry
INOVIO PHARMA (INO)
$1.19-$0.02 (-2.07%)
INO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.21 | ||
Change | -$0.01 (-0.82%) | ||
Open | $1.24 | ||
High | $1.26 | ||
Low | $1.20 | ||
Previous Close | $1.22 | ||
Volume | 1,939,664 | ||
30-Day Average Volume | 2,863,638 | ||
1-Week Change | 0.00% | ||
1-Month Change | -9.02% | ||
1-Year Change | -50.81% | ||
3-Year Change | -74.08% | ||
5-Year Change | -98.50% | ||
Fundamentals | |||
Shares Outstanding | 103.4M | ||
Total Assets | $49.4M | ||
Market Cap | $125.1M | ||
Enterprise Value | $93.6M | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$6.0M | ||
Free Cash Flow | -$18.0M | ||
EBIT | -$6.0M | ||
EBITDA | -$5.7M | ||
Net Working Capital | -$1,810.00 | ||
EPS | -$0.07 | ||
Enterprise Value/EBITDA | -16 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 29 | ||
P/E | -17 | ||
PEG | -0 | ||
Price/Free Cash Flow | -7 | ||
Price/Operating Cash Flow | -7 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 12 | ||
Last Split Date | 01/25/2024 | ||
Earnings & Revenue